Bryant Fong

Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI.

Odyssey Thera, Inc. operates as a biopharmaceutical company. The company was founded by John Westwick and Stephen W. Michnick in 2000 and is headquartered in San Ramon, CA.

Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX.

Logical Therapeutics, Inc. develops products that treat diseases associated with inflammation. It provides a platform of bio-activated prodrugs for the chronic treatment of arthritis. Its bio-activated NSAID prodrugs are chemical entities that are designed to reduce the incidence of GI ulcers and improve GI tolerability in patients who require chronic NSAID treatment. The company was founded by Carolyn E. Green in 2005 and is headquartered in Waltham, MA.

FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA.

Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA.

AliveCor, Inc. develops mobile heart monitoring system. It offers kardia mobile that provides people with suspected or diagnosed heart conditions, and those at risk of heart conditions. The company was founded by David E. Albert, Bruce Satchwell, and Kim Barnett and is headquartered in San Francisco, CA.

Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan.

Biomark Capital Management Co. LLC (Biomark Capital) is a private equity and venture capital firm founded in 2011 by David S. Wetherell. The firm is headquartered in Greenwich, Connecticut.

I2Dx, Inc. Develops diagnostic platform for the assessment of prodromal Alzheimer’s disease. The company was founded by Janos Redei and is headquartered in Palo Alto, CA.

Biozeus Biopharmaceutical SA operates as a drug development company. It engages in the identifying early-stage drug candidates from Brazilian research institutions and develop them into new therapies for improving and saving lives, worldwide. The company is headquartered in Rio de Janeiro, Brazil.

FinHealth Gestão de Recursos SA (FinHealth) an independent private equity and venture capital firm headquartered in Rio de Janeiro, Brazil. It was founded in 2010.

Deep Medicine Acquisition Corp. is a blank check company, which aims on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on July 8, 2020 and is headquartered in New York, NY.